Perceptive Advisors as of Sept. 30, 2011
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 57 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 12.2 | $26M | 415k | 61.91 | |
| Neurocrine Biosciences (NBIX) | 7.5 | $16M | 2.6M | 5.98 | |
| Aegerion Pharmaceuticals | 7.4 | $16M | 1.2M | 12.67 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.3 | $13M | 300k | 44.46 | |
| Ariad Pharmaceuticals | 5.8 | $12M | 1.4M | 8.79 | |
| Endo Pharmaceuticals | 4.2 | $9.0M | 320k | 27.99 | |
| Endocyte | 4.2 | $8.9M | 843k | 10.60 | |
| Repros Therapeutics | 4.1 | $8.6M | 2.3M | 3.73 | |
| Impax Laboratories | 3.8 | $8.0M | 446k | 17.91 | |
| Capital Senior Living Corporation | 3.0 | $6.3M | 1.0M | 6.17 | |
| Trimeris | 2.8 | $5.9M | 2.3M | 2.52 | |
| Amgen | 2.8 | $5.8M | 106k | 54.96 | |
| Avi Biopharma | 2.8 | $5.8M | 5.2M | 1.12 | |
| Shire | 2.7 | $5.8M | 61k | 93.93 | |
| Pharmacyclics | 2.4 | $5.1M | 432k | 11.83 | |
| Abbott Laboratories | 2.2 | $4.6M | 90k | 51.14 | |
| Johnson & Johnson (JNJ) | 2.1 | $4.5M | 70k | 63.69 | |
| NPS Pharmaceuticals | 2.1 | $4.5M | 685k | 6.51 | |
| Allergan Inc Com Stk | 2.1 | $4.5M | 54k | 82.38 | |
| Express Scripts | 2.0 | $4.3M | 116k | 37.07 | |
| Pharmasset | 1.9 | $4.1M | 50k | 82.38 | |
| Human Genome Sciences | 1.3 | $2.8M | 220k | 12.69 | |
| Athersys | 1.3 | $2.6M | 1.5M | 1.76 | |
| Examworks | 1.1 | $2.4M | 232k | 10.18 | |
| Optimer Pharmaceuticals | 1.0 | $2.1M | 150k | 13.84 | |
| Immunomedics | 0.9 | $2.0M | 612k | 3.20 | |
| D Alexion Pharmaceutic Als Inc C Common Stock 0 | 0.9 | $1.9M | 30k | 64.07 | |
| Trius Therapeutics | 0.9 | $1.9M | 301k | 6.30 | |
| Hologic (HOLX) | 0.8 | $1.8M | 118k | 15.21 | |
| Response Genetics (RGDXQ) | 0.8 | $1.7M | 912k | 1.90 | |
| Neptune Technologies Bioreso | 0.8 | $1.7M | 654k | 2.61 | |
| Bristol Myers Squibb (BMY) | 0.7 | $1.6M | 50k | 31.38 | |
| Onyx Pharmaceuticals | 0.7 | $1.5M | 50k | 30.02 | |
| Exelixis (EXEL) | 0.7 | $1.4M | 250k | 5.46 | |
| Trinity Biotech | 0.5 | $1.1M | 119k | 9.16 | |
| Affymax (AFFY) | 0.4 | $897k | 200k | 4.48 | |
| Neostem (NBS) | 0.4 | $827k | 1.3M | 0.65 | |
| Solta Medical | 0.3 | $729k | 583k | 1.25 | |
| BioSante Pharmaceuticals | 0.3 | $684k | 300k | 2.28 | |
| BioDelivery Sciences International | 0.3 | $656k | 602k | 1.09 | |
| Dynavax Technologies Corporation | 0.2 | $428k | 230k | 1.86 | |
| SIGA Technologies (SIGA) | 0.2 | $327k | 100k | 3.27 | |
| iShares Russell 2000 Index (IWM) | 0.1 | $322k | 5.0k | 64.40 | |
| Somaxon Pharmaceuticals | 0.1 | $268k | 308k | 0.87 | |
| LeMaitre Vascular (LMAT) | 0.1 | $254k | 41k | 6.21 | |
| Array BioPharma | 0.1 | $195k | 100k | 1.95 | |
| NxStage Medical | 0.1 | $156k | 7.5k | 20.80 | |
| INC Ventrus Biosciences | 0.1 | $110k | 12k | 9.02 | |
| Allos Therapeutics | 0.0 | $92k | 50k | 1.84 | |
| Epocrates | 0.0 | $77k | 8.5k | 9.06 | |
| Abiomed Inc Com Stk | 0.0 | $55k | 5.0k | 11.00 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $53k | 50k | 1.06 | |
| Uroplasty | 0.0 | $49k | 10k | 4.90 | |
| Senesco Technologies | 0.0 | $51k | 223k | 0.23 | |
| Auxilium Pharmaceuticals | 0.0 | $15k | 1.0k | 15.00 | |
| TranS1 (TSON) | 0.0 | $7.0k | 2.3k | 3.01 | |
| Combimatrix Corporation *w exp 05/01/201 | 0.0 | $10k | 50k | 0.20 |
